Categories: All postsAnalysts

Tucows is fully valued, Echelon Wealth Partners says

Weaker than expected gross margins contributed to a disappointing second quarter bottom line for Tucows Inc. (TSX:TC, NASDAQ:TCX), says analyst Ralph Garcea of Echelon Wealth Partners, who on Thursday maintained his “Hold” recommendation with a lowered price target of C$75.00 (previously C$80.00).

Internet services company Tucows reported its Q2/2018 results on Thursday, posting an Adjusted EBITDA of $11.2 million on revenue of $81.1 million and EPS of $0.33 (all figures in US dollars unless noted otherwise).

The company’s wireless service and fibre Internet provider Ting saw gross margin for the quarter of roughly 27 per cent, which came in below Garcea’s estimate of 38 per cent. The analyst expressed skepticism on Tucow’s ability to generate the profits for 2018 that management previously proposed and restated on Wednesday.

“The company reiterated guidance of $54 million in Adjusted EBITDA for 2018; we assert the likelihood of the guidance to be below the probability of meeting it due to fibre delays and lack of margin robustness given how H118 has gone,” says Garcea.

“Tucows’ strong growth initiatives in fibre are costly, but over time provide a robust risk/reward with its de-risking techniques,” says the analyst. “With cash sitting at $11.2 million, quarterly CFOPS of ~$12-15 million plus, and a credit facility of up to $140 million, we believe TC has ample financing needed to expand Ting Mobile/Internet.”

Garcea says based on his 2018 estimates, Tucows is currently trading at an EV/Sales, EV/EBITDA and P/E of 1.9x, 12.9x, and 26.9x, respectively, versus its Internet domain sector peer averages of 6.1x, 19.1x and 20.1x, respectively.

The analyst’s reduced price target of C$75.00 represents a projected return of one per cent at the time of publication.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: tc
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Should you buy AMZN? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Amazon (Amazon Stock… [Read More]

3 hours ago

These cannabis stocks will benefit most from reclassification

It happened. The move that everyone in the cannabis sector was hoping for came about swiftly on the last day… [Read More]

10 hours ago

Is AMD stock a buy? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Suji Desilva has maintained his "Buy" rating on Advanced Micro Devices… [Read More]

11 hours ago

Is Wolfspeed stock still a buy?

Ahead of the company's third quarter results, Roth MKM analyst Scott Irwin has maintained his "Buy" rating on Wolfspeed (Wolfspeed… [Read More]

12 hours ago

WELL Health inks five-year deal with Microsoft

It's become one of the biggest players in the Canadian healthcare space, now WELL Health (WELL Health Stock Quote, Chart,… [Read More]

1 day ago

Is Thomson Reuters stock a buy right now?

Its stock has made a since last October, but is there more upside left in Thomson Reuters (Thomson Reuters Stock… [Read More]

1 day ago